Corporate Banner
Satellite Banner
Genomics
Scientific Community
 
Become a Member | Sign in
Home>Events>This Event
  Events - October 2013


Drug Discovery Week Europe (DDWE)

07 Oct 2013 - 10 Oct 2013 - Berlin, Germany



Bookmark and Share


Speedier processes, cost reduction and the personalization of therapeutics are at the forefront among many of the challenges involved for drug discovery and development. The recent advances in both biomarker development and next generation sequencing have provided promising opportunities to overcoming such challenges.

 

Biomarkers are a dynamic and potent tool in understanding the predication, cause, diagnosis, progression, regression, or outcome of the treatment of diseases. They also play a critical role in lead discovery and optimization, target validation, animal models, drug safety assessment and clinical trials.

 

Next generation sequencing technologies have dramatically increased the speed and reduced costs of sequencing. These technologies have made it possible to compare genetic sequences among multiple genomes; data comparisons between individual patients, populations, or normal and pathologic cells are now a reality.

 

GTC’s Drug Discovery Week Europe (DDWE) will have over 400 attendees with conferences covering biomarker research, biomarker development, next generation sequencing and bioinformatics.

DDWE will comprise of four conferences across four days:

I. Next-Generation Sequencing: Opportunities & Challenges
II. Bioinformatics & Data Management 
III. Biomarkers in Drug Discovery & Development 
IV. Biomarkers in Diagnostics 



Further information
Scientific News
Improving Regenerative Medicine
Lab-created stem cells may lack key characteristics, UCLA research finds.
Tick Genome Reveals Secrets of a Successful Bloodsucker
NIH has announced that decipher the genome of the blacklegged tick which could lead to new tick control methods.
"Dark Side" of the Transcriptome
New approach to quantifying gene "read-outs" reveals important variations in protein synthesis and has implications for understanding neurodegenerative diseases.
Individuals' Medical Histories Predicted by their Noncoding Genomes
Researchers have found that analyzing mutations in regions of the genome that control genes can predict medical conditions such as hypertension, narcolepsy and heart problems.
New Source of Mutations in Cancer
Recently, a new mutation signature found in cancer cells was suspected to have been created by a family of enzymes found in human cells called the APOBEC3 family.
Advancing Synthetic Biology
Living systems rely on a dizzying variety of chemical reactions essential to development and survival. Most of these involve a specialized class of protein molecules — the enzymes.
Biosensors on Demand
New strategy results in custom "designer proteins" for sensing a variety of molecules.
Unique Mechanism for a High-Risk Leukemia
Researchers uncovered the aberrant mechanism underlying a notoriously treatment-resistant acute lymphoblastic leukemia subtype; findings offer lessons for understanding all cancers.
Genetically Mapping the Most Lethal E.Coli Strains
New approach could lead to fewer deaths, and new treatments.
Pumpjack" Mechanism for Splitting and Copying DNA
High-resolution structural details of cells' DNA-replicating proteins offer new insight into how these molecular machines function
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,900+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,200+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!